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are “safe” may be contributing factors to their misuse. Hence,
a major target for intervention is the general public, including
parents and youth, who must be better informed about the
negative consequences of sharing with others medications
prescribed for their own ailments. Equally important is the
improved training of medical practitioners and their staff to
better recognize patients at potential risk of developing non-
medical use, and to consider potential alternative treatments
as well as closely monitor the medications they dispense to
these patients.
The United Nations Office of Drugs and Crime is already
assisting several governments in collecting epidemiologic data
more efficiently as well as developing monitoring and training
programs that ensure these drugs are available to those who
need them while strictly avoiding diversion for nonmedical
purposes.
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The concept of basic symptoms: its scientific and clinical relevance
The concept of basic symptoms originates from retrospective
descriptions of the prodromal phase of schizophrenia, pub-
lished in the first half of the 20th century and continuously
developed through its second half1. It was not until the mid
1990s, however, that basic symptoms attracted a broad attention
within two main lines of research: an empirical approach to ear-
ly detection of psychosis2 and a heuristic approach to define the
Gestalt of schizophrenia by so-called “self-disorders”3.
Basic symptoms are subtle, subjectively experienced distur-
bances in mental processes including thinking, speech, atten-
tion, perception, drive, stress tolerance, and affect1,2,4. Following
training, they can be reliably assessed with a clinical interview
from age 8 onwards using the youth and adult version of the
Schizophrenia Proneness Instrument5,6 (available at www.
basicsymptoms.org). They have been reported in all stages of
psychotic disorders, including prodromes and acute states of
first episode and relapse, as well as residual states1,2,4.
Basic symptoms are regarded as an immediate symptomatic
expression of the neurobiological processes underlying psycho-
sis and the earliest form of self-experienced symptoms – hence
the term “basic”. In contrast, attenuated and overt psychotic
symptoms are assumed to develop later, as a result of poor cop-
ing with initial symptoms, such as basic symptoms, or stressors,
when a vulnerable individual’s protective mechanisms are over-
strained1,4. With its focus on the emerging disorder, the concept
of basic symptoms has been linked to a better understanding of
the origins of psychoses, in particular schizophrenia, and to an
improvement of their (early) diagnosis and treatment.
Initially, two criteria for the identification of basic symp-
toms were developed: cognitive-perceptive basic symptoms
(COPER) and cognitive disturbances (COGDIS)1,2,4. COGDIS
requires two of nine cognitive basic symptoms to occur at least
once per week and is increasingly used as a clinical high-risk
criterion in addition to ultra-high risk criteria2,7. The first
meta-analysis comparing various clinical high-risk criteria
found pooled conversion rates in COGDIS-defined samples of
up to 61% at follow-ups of more than four years. Medium- and
long-term pooled conversion rates of COGDIS samples were
significantly higher than those of ultra-high risk criteria sam-
ples7. Thus, the European Psychiatric Association recommended
ultra-high risk criteria and COGDIS to be used alternatively
for psychosis risk assessment7. However, the presence of both
COGDIS and ultra-high risk criteria appears to increase psychosis
predictability compared to either criterion alone2.
In spite of their neurobiological conceptual foundation,
basic symptoms have only recently been considered in neuro-
biological studies of psychosis. Several correlates of these
symptoms in psychotic and clinical high-risk individuals have
been reported. These included changes in event-related poten-
tials, neural oscillations, neurotransmitter systems, and large-
scale networks as assessed with functional magnetic resonance
imaging4. However, there is a need for further studies in clinical
and non-clinical samples exploring the neurobiological corre-
lates of individual basic symptoms and their relevance to the
development of psychosis4.
The basic symptoms concept has informed research on altera-
tions of the very experience of the self as a core feature of schizo-
phrenia3,8. Within this line of research, basic symptoms are an
integral part of the so-called “anomalous self-experiences”,
“(basic) self-disturbances” or “self-disorders”3. Starting with
E. Bleuler’s characterization of schizophrenia as “a loss of unity of
the personality”, self-disturbances have always had a central role
in the concept of schizophrenia, being explored by authors such
as Minkowski and Blankenburg. Currently, alterations in self-
disturbances, including the “development of an integrated sense
of self” are believed to have commonunderlying neurobiological
mechanisms8. Basic symptoms offer an empirical approach to
test related hypotheses, such as perceptual incoherence or
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progressive neurodevelopmental alterations (e.g., aberrant syn-
aptic pruning) affecting the “neural circuitry of self”8.
Another fundamental objective of research on basic symp-
toms has been to gain a better understanding of residual states.
The assessment of basic symptoms can help evaluate the level of
remission and guide treatment through combinations of phar-
macological, psychological and rehabilitative interventions. Fur-
thermore, treatment compliance might be improved by relating
therapeutic strategies to basic symptoms that are self-recognized
as deviations from “normal” mental processes. Finally, the rec-
ognition of basic symptoms can help educate patients and their
families about the manifestation of psychosis and the expected
changes that occur in the disorder, which is an important step
towards stripping fear and unpredictability from “madness”1,9.
In summary, the concept of basic symptoms has recently
started to reveal its potential in psychosis research. So far, it is
mainly recognized for its contribution to early psychosis detec-
tion and exploration of self-disorders as the assumed core Gestalt
of schizophrenia. Deeper insight into the neurobiological origins
of psychosis using the concept is only just emerging and will
depend on its reliable assessment.
The benefit of the concept to psychosis treatment has
unfortunately not been explored systematically. Furthermore,
although basic symptoms are perceived as an integral part of
psychotic disorders, several of them may also occur in other
mental disorders, in particular organic and mood disorders10.
However, the utility of the assessment of these symptoms outside
the psychosis field has not yet been investigated. Thus, in many
ways, the full potential of the concept remains unexplored.
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